L01FY01 - pertuzumab and trastuzumab ; Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.